Abstract | INTRODUCTION: MATERIAL AND METHODS: EAE induction was performed in female C57BL/6 mice by myelin oligodendrocyte glycoprotein (35-55) (MOG35-55) in Complete Freund's Adjuvant (CFA) emulsion, and Peg-IFN α-2a was used for the treatment of EAE. During the course of the study, clinical evaluation was assessed, and on day 21 post-immunisation blood samples were taken from the heart of mice for evaluation of IL-6, and enzymatic and non-enzymatic antioxidants. The mice were sacrificed and the brains and cerebellums were removed for histological analysis. RESULTS: Our findings indicated that Peg-IFN α-2a had beneficial effects on EAE by attenuation of the severity and a delay in the onset of disease. Histological analysis showed that treatment with Peg-IFN α-2a can reduce inflammation criteria. Moreover, in Peg-IFN α-2a-treated mice the serum level of IL-6 was significantly less than in controls, and total antioxidant capacity was significantly more than in the control animals. CONCLUSIONS: These data indicate that Peg-IFN α-2a as an anti- serine protease with immunomodulatory properties may be useful for the treatment of MS.
|
Authors | Sanaz Afraei, Reza Sedaghat, Farzaneh Tofighi Zavareh, Zahra Aghazadeh, Parvin Ekhtiari, Gholamreza Azizi, Abbas Mirshafiey |
Journal | Central-European journal of immunology
(Cent Eur J Immunol)
Vol. 43
Issue 1
Pg. 9-17
( 2018)
ISSN: 1426-3912 [Print] Poland |
PMID | 29731688
(Publication Type: Journal Article)
|